ExiVex reports in-human pharmacokinetic data showing EMRX-101 intranasal naloxone approaches IV-like peak plasma concentrations with substantially faster Tmax than currently approved comparator
The Race Against Time: The Evolution of Rapid-Onset Emergency Therapeutics In the high-stakes environment of emergency medicine, the difference between a successful intervention and a tragic outcome is often measured in seconds. As the landscape of opioid crises evolves—particularly with the prevalence of high-potency synthetic opioids like fentanyl—the demand for faster, more potent delivery systems … Read more